-
CHALLENGES FOR THE ECONOMIC EVALUATION OF DIAGNOSTIC TECHNOLOGIES: A REVIEW AND TAXONOMY
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF THE RETINAL VASCULAR DISEASE QUESTIONNAIRE TO ASSESS VISUAL SYMPTOMS, VISION-RELATED IMPACTS, AND TREATMENT SATISFACTION IN DR, DME, AND NAMD
Aug 11, 2026, 17:16 PM -
DEPRESSION AND ANXIETY AS DETERMINANTS OF PATIENT-REPORTED OUTCOMES IN INFLAMMATORY ARTHRITIS: A SYSTEMATIC REVIEW WITH IMPLICATIONS FOR HEALTH ECONOMIC MODELING
Aug 11, 2026, 17:16 PM -
IMPACT OF MISSED BIOMARKER DOCUMENTATIONON REAL-WORLD EVIDENCE VALIDITY IN LUNG CANCER STUDIES
Aug 11, 2026, 17:16 PM -
COST PER QALY UP TO FIVE YEARS AFTER ICU ADMISSION AMONG ICU SURVIVORS: A MULTICENTER COHORT STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE, DACARBAZINE, AND DEXAMETHASONE (BRECADD) IN NEWLY DIAGNOSED ADVANCED STAGE HODGKIN LYMPHOMA FROM THE ITALY HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
COST EFFECTIVENESS OF ONASEMNOGENE ABEPARVOVEC IN THE TREATMENT OF PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY IN TURKIYE
Aug 11, 2026, 17:16 PM -
REAL-WORLD DISABILITY AND BURDEN AMONG PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Aug 11, 2026, 17:16 PM -
HEALTHCARE EXPENDITURES ASSOCIATED WITH BODY MASS INDEX IN ADULTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Aug 11, 2026, 17:16 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON OF ZILUCOPLAN VERSUS CEMDISIRAN AND GEFURULIMAB IN GENERALISED MYASTHENIA GRAVIS (GMG)
Aug 11, 2026, 17:16 PM -
CAPTURING PREFERENCE DYNAMICS IN DHT-SUPPORTED OBESITY CARE: A LONGITUDINAL HEALTH PREFERENCE RESEARCH STUDY EMBEDDED IN THE UNIFIED OBESITY USE CASE
Aug 11, 2026, 17:16 PM -
A RAPID APPROACH TO HIGH-VOLUME ABSTRACT SCREENING FOR EXPLORATORY LITERATURE REVIEWS USING BIOMEDICAL TRANSFORMERS
Aug 11, 2026, 17:16 PM -
PERFORMANCE OF ARTIFICIAL INTELLIGENCE (AI) AS A SECOND REVIEWER IN TITLE/ABSTRACT SCREENING: EVIDENCE FROM 30 HEALTH TECHNOLOGY ASSESSMENT-FOCUSED SYSTEMATIC LITERATURE REVIEWS (SLRS)
Aug 11, 2026, 17:16 PM -
REVISITING THE LENGTH OF STAY "SWEET SPOT" AFTER HFREF HOSPITALIZATION USING DAYS ALIVE AND OUT OF HOSPITAL
Aug 11, 2026, 17:16 PM -
THE HEALTH IMPACT OF PEMBROLIZUMAB FOR THE FIRST-LINE TREATMENT FOR PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER (PRMCC) IN TURKIYE
Aug 11, 2026, 17:16 PM -
AMBULATORY CARDIAC MONITORING UTILIZATION AND GUIDELINE ALIGNMENT AMONG SYMPTOMATIC ARRHYTHMIA-NAIVE PATIENTS IN ENGLAND: A REAL-WORLD EVIDENCE STUDY
Aug 11, 2026, 17:16 PM -
REAL-WORLD DATA ON INTRAVENOUS AND ORAL ANTINEOPLASTIC TREATMENTS OVER 20 YEARS (2005-2024) AT A TERTIARY HOSPITAL
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF EXPANDING INTRANASAL INFLUENZA VACCINATION IN PAEDIATRIC HIGH-RISK POPULATIONS IN GERMANY
Aug 11, 2026, 17:16 PM -
UTILITY AND DISUTILITY VALUES FOR STROKE, MYOCARDIAL INFARCTION AND RELATED CARDIOVASCULAR HEALTH STATES: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
AI AS A SECOND REVIEWER: ASSESSING A LANGUAGE MODEL'S SUITABILITY FOR ABSTRACT SCREENING IN SYSTEMATIC AND SCOPING REVIEWS
Aug 11, 2026, 17:16 PM
